Background:There is growing evidence that the gene named tumor necrosis factorα–induced protein 6(TNFAIP6)has an important role in various tumors.However,a systematic pan-cancer analysis of TNFAIP6 is lacking.Here w...Background:There is growing evidence that the gene named tumor necrosis factorα–induced protein 6(TNFAIP6)has an important role in various tumors.However,a systematic pan-cancer analysis of TNFAIP6 is lacking.Here we aimed to analyze the expression of TNFAIP6 across multiple cancers and verify its expression during the progression of colon cancer.Methods:We performed a comprehensive bioinformatics analysis to examine the expression of TNFAIP6 across 27 tumor types.GEPIA2 was used to evaluate the effect of TNFAIP6 on clinical cancer prognosis.cBioportal was used to assess TNFAIP6 mutations.The correlation between TNFAIP6 and cancer immune infiltrates was explored using TIMER2.0.The CancerSEA database was used to perform functional analysis of TNFAIP6.Metascape was used to identify TNFAIP6-related gene enrichment pathways.Immunohistochemistry was performed to detect TNFAIP6 protein expression in the colon cancer.In addition,the Comparative Toxicogenomics Database was searched for known and possible antitumor drugs that may be associated with TNFAIP6.Results:We found that,in most of the cancers included in this analysis,TNFAIP6 was highly expressed,and there is a distinct relationship between TNFAIP6 expression and cancer prognosis.TNFAIP6 expression is associated with cancer-associated fibroblasts,neutrophils,and endothelial cells.TNFAIP6 and similar genes may also be involved in the PID_VEGF_VEGFR_pathway.Immunohistochemistry revealed an increasing trend of TNFAIP6 protein expression in normal,adenoma,and colon cancer tissues.Several known and possible antitumor drugs that may be associated with TNFAIP6 were identified in the Comparative Toxicogenomics Database.These results suggest that a number of drugsmay target TNFAIP6 during cancer treatment,including cisplatin,irinotecan,resveratrol,U 0126,NSC689534,genistein,NSC668394,oxaliplatin,plerixafor,topotecan,vincristine,flutamide,doxorubicin,MRK 003,folic acid,demecolcine,tunicamycin,zoledronic acid,and schizandrin B.Conclusions:TNFAIP6 may function as an oncogene in certain cancers.Furthermore,this study provides evidence that TNFAIP6 is an important factor in colon cancer progression.展开更多
目的研究肿瘤坏死因子α诱导蛋白3(tumor necrosis factorα-induced protein 3,TNFAIP3)在食管鳞癌中表达的临床病理意义及其对鳞癌预后的判断价值。方法免疫组织化学法检测100例随访食管鳞癌及80例癌旁组织中TNFAIP3蛋白的表达,并分...目的研究肿瘤坏死因子α诱导蛋白3(tumor necrosis factorα-induced protein 3,TNFAIP3)在食管鳞癌中表达的临床病理意义及其对鳞癌预后的判断价值。方法免疫组织化学法检测100例随访食管鳞癌及80例癌旁组织中TNFAIP3蛋白的表达,并分析了其与食管鳞癌临床病理特征及预后的关系。结果TNFAIP3在食管鳞癌中高表达阳性率为47.0%(47/100),显著高于癌旁组织中的高表达率15.0%(12/80),且与肿瘤的分化程度有关;生存分析显示高表达TNFAIP3的患者预后不良,单因素生存分析显示TNFAIP3的表达、肿瘤的浸润深度、淋巴结转移、临床分期与食管鳞癌预后密切相关,多因素生存分析显示TNFAIP3的表达、肿瘤的浸润深度、淋巴结转移、临床分期为食管鳞癌的独立预后预测因子。结论表达增高的TNFAIP3可能参与了食管鳞癌的发生发展,TNFAIP3的高表达可能成为食管鳞癌的独立预后因子。展开更多
基金funded by the Natural Science Basic Research Pro-gram of Shaanxi(no.2023-JC-QN-0876)Key Research and Development Program of Shaanxi(no.2023-YBSF-447).
文摘Background:There is growing evidence that the gene named tumor necrosis factorα–induced protein 6(TNFAIP6)has an important role in various tumors.However,a systematic pan-cancer analysis of TNFAIP6 is lacking.Here we aimed to analyze the expression of TNFAIP6 across multiple cancers and verify its expression during the progression of colon cancer.Methods:We performed a comprehensive bioinformatics analysis to examine the expression of TNFAIP6 across 27 tumor types.GEPIA2 was used to evaluate the effect of TNFAIP6 on clinical cancer prognosis.cBioportal was used to assess TNFAIP6 mutations.The correlation between TNFAIP6 and cancer immune infiltrates was explored using TIMER2.0.The CancerSEA database was used to perform functional analysis of TNFAIP6.Metascape was used to identify TNFAIP6-related gene enrichment pathways.Immunohistochemistry was performed to detect TNFAIP6 protein expression in the colon cancer.In addition,the Comparative Toxicogenomics Database was searched for known and possible antitumor drugs that may be associated with TNFAIP6.Results:We found that,in most of the cancers included in this analysis,TNFAIP6 was highly expressed,and there is a distinct relationship between TNFAIP6 expression and cancer prognosis.TNFAIP6 expression is associated with cancer-associated fibroblasts,neutrophils,and endothelial cells.TNFAIP6 and similar genes may also be involved in the PID_VEGF_VEGFR_pathway.Immunohistochemistry revealed an increasing trend of TNFAIP6 protein expression in normal,adenoma,and colon cancer tissues.Several known and possible antitumor drugs that may be associated with TNFAIP6 were identified in the Comparative Toxicogenomics Database.These results suggest that a number of drugsmay target TNFAIP6 during cancer treatment,including cisplatin,irinotecan,resveratrol,U 0126,NSC689534,genistein,NSC668394,oxaliplatin,plerixafor,topotecan,vincristine,flutamide,doxorubicin,MRK 003,folic acid,demecolcine,tunicamycin,zoledronic acid,and schizandrin B.Conclusions:TNFAIP6 may function as an oncogene in certain cancers.Furthermore,this study provides evidence that TNFAIP6 is an important factor in colon cancer progression.
文摘目的研究肿瘤坏死因子α诱导蛋白3(tumor necrosis factorα-induced protein 3,TNFAIP3)在食管鳞癌中表达的临床病理意义及其对鳞癌预后的判断价值。方法免疫组织化学法检测100例随访食管鳞癌及80例癌旁组织中TNFAIP3蛋白的表达,并分析了其与食管鳞癌临床病理特征及预后的关系。结果TNFAIP3在食管鳞癌中高表达阳性率为47.0%(47/100),显著高于癌旁组织中的高表达率15.0%(12/80),且与肿瘤的分化程度有关;生存分析显示高表达TNFAIP3的患者预后不良,单因素生存分析显示TNFAIP3的表达、肿瘤的浸润深度、淋巴结转移、临床分期与食管鳞癌预后密切相关,多因素生存分析显示TNFAIP3的表达、肿瘤的浸润深度、淋巴结转移、临床分期为食管鳞癌的独立预后预测因子。结论表达增高的TNFAIP3可能参与了食管鳞癌的发生发展,TNFAIP3的高表达可能成为食管鳞癌的独立预后因子。